MPLX LP vs Nuwellis Inc — how do they compare? MPLX LP trades at $56.64 (market cap $57.97B), while Nuwellis Inc trades at $2.94 (market cap $1.09M). The key difference: MPLX LP is far larger — about 53183.5× Nuwellis Inc's market cap, and MPLX LP pays a 7.54% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| MPLX | NUWE | |
|---|---|---|
Market Cap | $57.97B | $1.09M |
Sector | Technology | Technology |
52-Week High | $59.17 | $527.46 |
52-Week Low | $47.80 | $2.80 |
Enterprise Value | $82.60B | -$722.58K |
Dividend Yield | 7.54% | — |
Signals from Pluang's Aura AI — not financial advice
MPLX trades at $57.13, showing modest daily gains of 0.12%. The stock maintains a bullish technical outlook with strong moving average signals, while fundamentals reveal robust profitability with 41.24% net margins and consistent earnings beats in recent quarters. Recent news highlights the company's resilient midstream business model and attractive dividend yield, with analyst consensus strongly favoring the stock.
Outlook remains positive given the 71% buy rating consensus and $60 price target representing 5% upside. Key risks include energy market volatility and the Q1 2026 earnings miss, but the company's fee-based contracts and Permian Basin exposure provide stability. The sustainable dividend and strong cash flow generation support long-term value for income-focused investors.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
MPLX LP is a Master Limited Partnership (MLP) formed by Marathon Petroleum Corporation (MPC). It is a diversified, growth-oriented company primarily engaged in the gathering, processing, and transportation of natural gas and natural gas liquids (NGLs), as well as the transportation, storage, and distribution of crude oil and refined petroleum products. MPLX owns and operates a network of midstream energy infrastructure assets, providing essential services to the energy industry across the United States.
Read more on MPLX →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →